Industry ownership intelligence

Medical Devices insider conviction

Executive and director activity assessed across 83 companies for breadth, transaction quality, clustering, freshness, and directional conviction.

Market dashboard Healthcare sector Company signals Filing ledger Data API

49/100

Balanced insider tape

83/100 confidence

Level: Industry
Evidence window: Latest 90 days
Named insiders: 628
Latest evidence: 24 Jul 2026

Capital positioning read

Balanced insider tape

Acquisition and disposal evidence is mixed after low-information compensation and derivative activity is separated out.

Wait for clearer clustering

Evidence in favour

135 distinct acquisition events survive duplicate and security-type controls.
Participation spans 628 named insiders rather than one filing source.

Decision risks

Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.

Conviction49Balanced insider tape

Confidence83Deep evidence

Controlled events528directional common-share events

Company breadth83represented companies

Acquisition value$15.8Mnormalized amount

Disposal value$232.1Mnormalized amount

Flow regime

Twelve-week filing pressure

Shows the cadence and balance of the full filing tape.

30818 May

15825 May

30901 Jun

16008 Jun

15715 Jun

7922 Jun

11129 Jun

7006 Jul

4213 Jul

1920 Jul

027 Jul

003 Aug

AcquisitionsDisposalsScore 49 · Confidence 83

Relative positioning

Industry peer map

Current score with confidence.

Pharmaceutical RetailersConviction accumulation7216 confidence Medical DistributionAccumulation bias5965 confidence Drug Manufacturers - GeneralAccumulation bias5785 confidence BiotechnologyBalanced insider tape5184 confidence Medical DevicesBalanced insider tape4983 confidence Diagnostics & ResearchDistribution bias4286 confidence Medical Instruments & SuppliesDistribution bias4284 confidence Medical Care FacilitiesDistribution bias3886 confidence Drug Manufacturers - Specialty & GenericDistribution bias3587 confidence Healthcare PlansDistribution bias3585 confidence Health Information ServicesDistribution bias3384 confidence

Directional balance

Controlled event mix

25.6%acquisition

Acquisition events: 135
Disposal events: 393
Net value: -$216.3M

Accumulation

Constructive company clusters

RCELAvita Medical Ltd8868 conf.TMCITreace Medical Concepts Inc8782 conf.RPIDRapid Micro Biosystems Inc8061 conf.STIMNeuronetics Inc7856 conf.NSPRInspireMD Inc7854 conf.CTSOCytosorbents Crp7840 conf.ENOVEnovis Corp7672 conf.TELATela Bio Inc7550 conf.

Distribution review

Disposal concentrations

CTKBCytek Biosciences Inc1270 conf.SYKStryker Corporation1271 conf.IRMDIradimed Co1273 conf.LUNGPulmonx Corp1277 conf.MASS908 Devices Inc1278 conf.DXCMDexCom Inc1287 conf.BFLYButterfly Network Inc1289 conf.HAEHaemonetics Corporation1471 conf.

Evidence density

Most active controlled tapes

STE29 controlled events27Concentrated distribution TNDM25 controlled events36Distribution bias QTRX23 controlled events34Distribution bias EW22 controlled events35Distribution bias IRMD22 controlled events12Concentrated distribution BFLY21 controlled events12Concentrated distribution CTKB19 controlled events12Concentrated distribution SIBN18 controlled events20Concentrated distribution

Evidence quality

What the filings represent

Common equity1080

Equity compensation310

Options and derivatives223

Other securities10

Decision makers

Role participation

Director867

Other executive302

CEO and chair158

Finance leadership129

Other or unspecified111

Large holder56

Quality controls

Evidence usability

Normalized values: 35%
Priced common share: 34%
Named insiders: 628
Controlled events: 528

Auditable evidence

Latest Medical Devices filings

Showing 691 to 720 of 1623.

5 Jun 2026

IRIXIRIDEX Corporation

DIZON, ROMEO RChief Financial Officer

AcquisitionCommon equity

$2.9KDirectional evidence

4 Jun 2026

GMEDGlobus Medical

RHOADS, ANN DDirector

DisposalOptions and derivatives